本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ovid Therapeutics Inc.

0.3469
+0.01013.00%
盘后0.37000.0231+6.66%19:03 EDT
成交量:63.48万
成交额:21.66万
市值:2,465.59万
市盈率:-0.93
高:0.3500
开:0.3500
低:0.3245
收:0.3368
数据加载中...
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/19

重要事件披露

8-K - Current report
2021/04/19

重要事件披露

8-K - Current report
2021/04/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/09

重要事件披露

8-K - Current report
2021/04/01

重要事件披露

8-K - Current report
2021/03/30

重要事件披露

8-K - Current report
2021/03/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/15

重要事件披露

8-K - Current report
2021/03/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/03

重要事件披露

8-K - Current report
2021/03/03

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals